BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18823436)

  • 21. Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells.
    Schroeder CP; Kadara H; Lotan D; Woo JK; Lee HY; Hong WK; Lotan R
    Cancer Res; 2006 Oct; 66(19):9762-70. PubMed ID: 17018636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
    Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
    Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting PI3K/Akt/HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis.
    Redlak MJ; Miller TA
    Dig Dis Sci; 2011 Feb; 56(2):323-9. PubMed ID: 20585984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Akt/PKB by a COX-2 inhibitor induces apoptosis in gastric cancer cells.
    Fan XM; Jiang XH; Gu Q; Ching YP; He H; Xia HH; Lin MC; Chan AO; Yuen MF; Kung HF; Wong BC
    Digestion; 2006; 73(2-3):75-83. PubMed ID: 16641552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
    Li CJ; Chang JK; Chou CH; Wang GJ; Ho ML
    Biochem Pharmacol; 2010 Mar; 79(6):926-37. PubMed ID: 19883628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling.
    Wang ZL; Fan ZQ; Jiang HD; Qu JM
    Carcinogenesis; 2013 Mar; 34(3):638-46. PubMed ID: 23172668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-cancer effect of COX-2 inhibitors on gastric cancer cells.
    Cho SJ; Kim N; Kim JS; Jung HC; Song IS
    Dig Dis Sci; 2007 Jul; 52(7):1713-21. PubMed ID: 17393325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
    Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L
    Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells.
    Thiel A; Heinonen M; Rintahaka J; Hallikainen T; Hemmes A; Dixon DA; Haglund C; Ristimäki A
    J Biol Chem; 2006 Feb; 281(8):4564-9. PubMed ID: 16371352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer.
    Tuynman JB; Vermeulen L; Boon EM; Kemper K; Zwinderman AH; Peppelenbosch MP; Richel DJ
    Cancer Res; 2008 Feb; 68(4):1213-20. PubMed ID: 18281498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt/GSK3beta/NAG-1 pathway.
    Pang RP; Zhou JG; Zeng ZR; Li XY; Chen W; Chen MH; Hu PJ
    Cancer Lett; 2007 Jun; 251(2):268-77. PubMed ID: 17257745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction.
    Jacobshagen C; Grüber M; Teucher N; Schmidt AG; Unsöld BW; Toischer K; Nguyen VP; Maier LS; Kögler H; Hasenfuss G
    Eur J Heart Fail; 2008 Apr; 10(4):334-42. PubMed ID: 18343721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro].
    Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823].
    Li Q; Peng J; Zhang GY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 33(12):1123-8. PubMed ID: 19141979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
    Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
    Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines.
    Wu GS; Zou SQ; Liu ZR; Tang ZH; Wang JH
    World J Gastroenterol; 2003 Jun; 9(6):1302-6. PubMed ID: 12800245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ; Janssen A; Schmidt R; Geisslinger G; Grösch S
    FASEB J; 2005 Aug; 19(10):1353-5. PubMed ID: 15946992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleomycin-induced nuclear factor-kappaB activation in human bronchial epithelial cells involves the phosphorylation of glycogen synthase kinase 3beta.
    Ma Y; Wang M; Li N; Wu R; Wang X
    Toxicol Lett; 2009 Jun; 187(3):194-200. PubMed ID: 19429264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.